Near-infrared Photoacoustic imaging (NIR-PA) can enable deep-tissue imaging, yet clinical translation has been hindered by a lack of suitable NIR-PA contrast agents. The FDA-approved Indocyanine green (ICG) dye is a promising candidate, but it offers limited targeting ability and poor stability. To address this unmet need, we examined three novel ICG-based platforms in the form of DNA scaffolds, J-aggregates, and nanobubbles. We demonstrate that all three platforms yield a PA signal stronger than whole blood at concentrations as low as 45 µM and are amenable to molecular targeting.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.